-
Aphena Pharma Completes $7M Expansion
americanpharmaceuticalreview
November 05, 2020
Aphena Pharma Solutions has completed its $7 million facility expansion and renovation in Easton, Maryland. The newly renovated, 30,000-square-foot facility and three large, high-end blending suites are open for new pharmaceutical business.
-
Aphena Pharma Completes $7M Facility Expansion
contractpharma
October 29, 2020
Newly renovated, 30,000-sq.-ft. facility and three large blending suites support liquids, creams, gels and suspensions.
-
Pharma urged to review anti-counterfeiting strategies ahead of no-deal Brexit
europeanpharmaceuticalreview
October 29, 2020
According to various associations, the UK could experience a high influx of counterfeit medicines if it leaves the EU without a deal.
-
Centre to come up with R&D policy for pharma sector: DoP Secretary
expresspharma
August 06, 2020
He informed that the government is planning to set up three national CoEs for drugs, medical devices in the country and NIPER Hyderabad will house one CoE for drug discovery.
-
Golden moment for India in key sectors including pharma over next 10 years: Venture capitalist
expresspharma
July 20, 2020
Indian ministers, key bureaucrats and technology industry leaders should put together a roadmap, set of regulations and authorisations so that companies can come in easily, says Silicon Valley entrepreneur and investor, MR Rangaswami.
-
Boston Scientific considers sale of speciality pharmaceutical unit
pharmaceutical-technology
July 16, 2020
Boston Scientific is considering the divestiture of its speciality pharmaceutical business, focused on snake venom treatments, reported Bloomberg citing people familiar with the matter.
-
NPPA fixes retail prices for 40 formulations
expresspharma
June 04, 2020
The authority has fixed prices for 40 different formulations produced by 12 manufacturers which applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013.
-
Jubilant Life Sciences posts Rs 260.49 cr profit for Jan-Mar
expresspharma
June 03, 2020
Drug firm Jubilant Life Sciences reported a consolidated net profit of Rs 260.49 crore for the quarter ended on March 31, 2020, driven by robust sales in the pharmaceuticals segment.
-
State Drug Controllers asked to help pharmaceutical firms in augmenting production of medicines
expresspharma
April 26, 2020
Secretary, DOP appreciated the efforts of all SDC’s and requested them to provide all support to manufacturing units with the help of local administration and concerned authorities by regular interaction so that there is no shortage of medicines and medic
-
COVID-19 highlighted vulnerabilities in medical manufacturing supply chain: Fitch
expresspharma
April 23, 2020
As per the report, as trade war has heightened discussion over the national security implications of manufacturing new technologies abroad, COVID-19 has highlighted vulnerabilities in the medical manufacturing supply chain, most notably in the US.